S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: anastrozole|DRUG: fulvestrant
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)|NCIC Clinical Trials Group